Posted by JohnB on December 2, 2000, at 11:59:46
In reply to Possible good news for sexual dysfunction, posted by PhoenixGirl on December 1, 2000, at 15:05:35
Drug helps put sex drive back in gear
By John Larabee, The Detroit NewsFor centuries, man has sought the perfect aphrodisiac.
Well, bless the Norwegians and the Swedes, they just may have found one.
Bearing the suggestive name LIBIDO (the area of the subconscious Freud thought controlled sexual impulses), the powdery substance, which is extracted from freeze-dried chicken egg embryos, was invented by a Norwegian university nutritionist who became fascinated with chickens when he was young.
The pill made from the substance has been the subject of two controlled studies in Norway and one study in Sweden.
Up to 80 percent of the men and women who received the treatment reported significant enhancement in their sex drive in the Swedish study.
North American clinical trials involving 500 men and 500 women will be run at 20 hospitals in Canada and the United States.
_________________________________New Drug Increases Sexual Desire When
Taking AntidepressantsJuly 17, 1996
LIBIDO(TM) (Ardor)(x), the breakthrough treatment recently introduced to combat reduced sexual desire, now has been shown to significantly improve sexual dysfunction associated with taking antidepressant drugs like Prozac, it was announced today.
Toronto Endocrinologist Dr. Jerald Bain told a news conference today that in four initial double blind and open trials, LIBIDO(TM) (Ardor) has shown excellent results in eliminating the frustrating side effects produced by antidepressants. The most serious side effect is the loss of interest in sex, which results in up to 1/3 of patients taking antidepressants discontinuing the drugs. The numbers would be much higher if all the patients with loss of sexual drive had realized that it was as a result of taking antidepressants.
LIBIDO(TM) (Ardor) is an oral agent made from chicken egg extract which has powerful aphrodisiac properties. It first made news last fall after positive test results in Norway prompted the arrangement of a clinical trial involving 1000 men and women across North America, the largest scientific study ever conducted on this subject.
The more recent studies tracked men and women who had reported lack of sexual desire while using antidepressants. The patients were given LIBIDO(TM) (Ardor) or placebo while continuing to take their medication. In a study conducted by Dr. Lance Levy, director of Toronto's Nutritional and Eating Disorders Clinic, men and women reported a "marked'' to "great'' improvement in sexual function after only the first two weeks of treatment with LIBIDO(TM) (Ardor).
"We are very encouraged by the preliminary findings,'' said Dr. Bjodne Eskeland, who conducted another of the antidepressant studies and is one of two researchers who developed LIBIDO(TM) (Ardor). "We anticipate that further antidepressant studies will show conclusively LIBIDO's(TM) (Ardor) ability to cause a definite improvement in sex drive, potentially eliminating one major side effect caused by these widely-prescribed medications.''
Antidepressants (which include Prozac, Luvox, Paxil, Zoloft and their generic equivalents) are taken by an estimated 20 million people worldwide. Studies have suggested that between 16 and 30 per cent of these patients have experienced the side effect of sexual dysfunction.(1) Some medical experts indicate this number may be as high as 78 per cent because the condition tends to be under-reported by patients.(2)
LIBIDO(TM) (Ardor) has been marketed in Norway as a dietary supplement since 1994. In the U.S.A., applications have been made to the U.S. Food and Drug Administration to sell LIBIDO(TM) (Ardor) as a food supplement and to the Health Protection Branch (HPB) of Health Canada to sell LIBIDO(TM) (Ardor) as a drug under a Doctor's prescription. A 90-day supply is currently available through MPS International or MPS Corp.
MPS International is a private company based in Barbados. It has the rights to market and distribute LIBIDO(TM) (Ardor) in the United States and Mexico, while its Canadian subsidiary, MPS Corp., owns the distribution rights in Canada.
So far, the FDA has approved a 90-day treatment as safe, but it has not yet decided if it really works. For now, doctors must authorize patient purchases directly from distributor MPS International of Toronto.
"If (LIBIDO) receives FDA efficacy clearance," an MPS spokesman said, "it will be available from pharmacists by prescription."
LIBIDO takes a minimum three weeks to have any effect and each three-week supply costs $100.
poster:JohnB
thread:49763
URL: http://www.dr-bob.org/babble/20001130/msgs/49807.html